提问
问诊
发现
计算
注册
注册
登录
登录
发现
Encorafenib Plus Binimetinib Yields Longest Reported Median Overall Survival in BRAF V600E-Mutant Metastatic NSCLC: Updated Phase 2 PHAROS Results - Vera Health News